|
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload |
09/09/2022 - 12:00pm to 1:00pm |
|
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD |
09/23/2022 - 12:00pm to 1:00pm |
|
Immunosuppressant Medication Use in Patients with Kidney Allograft Failure: A Prospective Multicenter Canadian Cohort Study |
10/07/2022 - 12:00pm to 1:00pm |
|
Removal of Uremic Solutes from Dialysate by Activated Carbon |
10/21/2022 - 12:00pm to 1:00pm |
|
Empagliflozin Patients with Chronic Kidney Disease |
12/16/2022 - 12:00pm to 1:00pm |
|
A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis |
01/20/2023 - 12:00pm to 1:00pm |
|
Risk of Symptomatic Kidney Stones During and After Pregnancy |
02/17/2023 - 12:00pm to 1:00pm |
|
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension |
03/10/2023 - 12:00pm to 1:00pm |
|
Role of Genomics in Kidney Transplantation |
04/07/2023 - 12:00pm to 1:00pm |
|
TMA and Kidney Transplant |
04/14/2023 - 12:00pm to 1:00pm |